|1.||Chen, Hsing I: 7 articles (04/2008 - 01/2006)|
|2.||Yoo, Sung-Eun: 6 articles (08/2010 - 02/2004)|
|3.||Kim, Hyunmi: 4 articles (04/2007 - 11/2005)|
|4.||Shin, Jae-Gook: 4 articles (04/2007 - 11/2005)|
|5.||Kim, Hyojin: 4 articles (04/2007 - 11/2005)|
|6.||Liu, Kwang-Hyeon: 4 articles (04/2007 - 11/2005)|
|7.||Popova, T N: 3 articles (09/2011 - 09/2009)|
|8.||Park, Jung-Woo: 3 articles (08/2010 - 08/2005)|
|9.||Jung, In-Sang: 3 articles (08/2010 - 08/2005)|
|10.||Chung, Hun-Jong: 3 articles (08/2010 - 08/2005)|
05/01/2007 - "The aim of this study is to evaluate meta-iodo-benzyl-guanidine scintigraphy in the diagnosis and the management of neuroblastoma. "
12/01/2006 - "Role of radio-iodinated meta-iodo benzyl guanidine in assessment of children with neuroblastoma at NEMROCK."
01/01/2000 - "Receptor binding (inhibition of [3H]-GR65630 binding) and agonist effects (stimulation of [14C]-guanidinium influx) at 5-HT3 receptors were studied in murine neuroblastoma N1E-115 cells, which express functional 5-HT3 receptors. "
08/12/1999 - "At least the guanidine derivative 4 might represent a potentially useful agent for imaging of neuroblastoma cells."
07/25/1997 - "Trophic action of pharmacological substances with a guanidine group on mouse neuroblastoma cells and chick ganglionic neurons in culture."
05/01/1975 - "Our experience showed that guanidine is also effective in botulism, type B, as adjunctive therapy."
07/01/1979 - "Among 14 patients who received conventional botulism therapy, there was no improvement in recovery rate in those who received guanidine compared with the nontreated group. "
05/01/1975 - "On two occasions, guanidine produced clinical and electrophysiological improvement in a 54-year-old man with botulism, type B. "
12/01/1979 - "Effect of guanidine on the neuromuscular block of botulism: an electrophysiological study."
04/06/2002 - "The specific treatments of botulism with serotherapy and with guanidine are of debatable efficacy. "
01/01/2008 - "We evaluated a guanidine-based-antibody-avidity assay in a selected group of recent (within six months from seroconversion) and chronic (more than forty eight months) HIV-1 infections in an attempt to shed more light on the significance of the avidity index in establishing the time of infection. "
09/01/2007 - "In vivo activity of a novel polymeric guanidine in experimental skin infection with methicillin-resistant Staphylococcus aureus."
02/01/2007 - "A guanidine-based antibody avidity assay for the identification of recently acquired human immunodeficiency virus type 1 (HIV-1) infection was evaluated. "
02/01/2004 - "However, infections containing 1 mM guanidine-HCl result in eIF4GI cleavage but only partial translation shutoff, indicating eIF4GI cleavage is insufficient for drastic translation inhibition. "
01/01/2003 - "This efflux occurred during both abortive infection (e.g., interrupted by guanidine-HCl and ending with apoptosis) and productive infection (leading to cytopathic effect). "
|4.||Lambert-Eaton Myasthenic Syndrome (Lambert-Eaton Syndrome)
09/01/1997 - "Guanidine hydrochloride is known to be highly effective in the symptomatic treatment of the Lambert-Eaton myasthenic syndrome (LEMS). "
10/01/1977 - "Eaton-Lambert syndrome: reflex improvement with guanidine."
01/14/1978 - "[A further case of Lambert-Eaton syndrome: remarkable action of guanidine]."
04/09/1977 - "Guanidine treatment and impaired renal function in the Eaton-Lambert syndrome."
10/01/1973 - "Guanidine hydrochloride in the Eaton-Lambert syndrome. "
|5.||Hepatocellular Carcinoma (Hepatoma)
07/01/1982 - "Replication of hepatitis A virus (HAV) in the human hepatoma-derived PLC/PRF/5 cell line was neither inhibited in the presence of various concentrations of guanidine or D-2-(alpha-hydroxybenzyl)benzimidazole (D-HBB), nor were the two chemicals effective in combination. "
11/01/2013 - "c-N-Methyl-N'-nitro-N-nitroso-guanidine HOS transforming gene (c-MET) is a new potential drug target for treatment of patients with hepatocellular carcinoma (HCC), and a recent study of a c-MET inhibitor in such patients has shown promising results. "
08/01/2013 - "Data on the clinicopathological features and prognostic impact of c-N-Methyl-N'-nitro-N-nitroso-guanidine HOS Transforming gene (c-MET) and hepatocyte growth factor (HGF) in hepatocellular carcinoma (HCC) are inconsistent. "
12/01/1974 - "Transfer-RNA methylase activity in rat ascites hepatomas: Altered methylation patterns in the presence of guanidine carbonate."
06/01/2003 - "Gene therapy for hepatocellular carcinoma using non-viral vectors composed of bis guanidinium-tren-cholesterol and plasmids encoding the tissue inhibitors of metalloproteinases TIMP-2 and TIMP-3."
|4.||Artificial Membranes (Artificial Membrane)
|5.||Gramicidin (Gramicidin A)
|7.||methanesulfonic acid (methanesulfonate)
|10.||Epithelial Sodium Channel
|5.||Renal Dialysis (Hemodialysis)